Kausik Ray, MD: Inclisiran for ASCVD
Mar 28, 2020, 03:08 PM
The ORION-11 principal investigator highlights new LDL-C reduction findings and teases future research for the siRNA-targeting drug.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.